Gene Therapy--Industry Impact


December 30, 2006
125 Pages - SKU: MC1460995
License type:
Gene Therapy in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Gene Therapy in Oncology Drug Pipeline Update 2013 There are today 120 companies plus partners developing 109 gene therapy drugs in 257 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated  |  read more...
$5,621.25
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)
12/17/2012 | published by: MarketsandMarkets
Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report  |  read more...
$4,650.00
Single-Use Technologies for Biopharmaceuticals: Global Markets
1/1/2013 | published by: BCC Research
This report provides: An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters Analyses of global market trends, with data from  |  read more...
$5,450.00
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards
6/25/2012 | published by: GBI Research
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research’s new report, “Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close  |  read more...
$3,500.00
Cancer Bundle
8/1/2012 | published by: TriMark Publications
The Cancer Reports Bundle includes the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately: Biomarker Technology Platforms for Cancer Diagnoses and  |  read more...
$26,010.00
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
6/12/2012 | published by: GBI Research
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications Summary GBI Research, the leading business intelligence provider, has released its latest research, “Translational Regenerative Medicine  |  read more...
$3,500.00
Gene Therapy in Oncology Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
There are today 117 companies plus partners developing 105 gene therapy drugs in 246 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last  |  read more...
$2,273.00
Translational Regenerative Medicine: Market Prospects 2012-2022
8/31/2012 | published by: Visiongain
New study shows you commercial potential of regenerative treatments See what the future holds for translational regenerative medicine. Visiongain's updated report lets you assess forecasted sales at overall world market, submarket, product  |  read more...
$2,739.00
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
4/12/2012 | published by: GlobalData
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders Summary GlobalData’s report, “Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders” takes a look at gene therapy for the treatment of blood disorders  |  read more...
$500.00
Global Gene Therapy Market Analysis
4/1/2012 | published by: RNCOS
In the past few years, gene therapy has come a long way to become one of the most sought after methods to develop a treatment. Despite being at a nascent stage in terms of revenue  |  read more...
$1,200.00